-
ARTH Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
Arch Therapeutics (ARTH)
Company Profile
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 4 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 3.00 mm |
Total shares | 1.05 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Oasis Capital | 303.14 k | $864.00 k |
wilson brandt | 300.00 k | $855.00 k |
Stahl Andrew | 300.00 k | $855.00 k |
Bigger Capital Fund L P | 150.00 k | $428.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Aug 23 | Laurence Hicks | Common Stock | Buy | Acquire P | Yes | No | 0.275 | 10,292 | 2.83 k | 10,292 |
31 Aug 23 | Laurence Hicks | Warrants Common Stock | Grant | Acquire A | Yes | No | 1 | 20,584 | 20.58 k | 20,584 |
31 Aug 23 | Norchi Terrence W | Common Stock | Buy | Acquire P | No | No | 0.275 | 6,862 | 1.89 k | 6,862 |
31 Aug 23 | Norchi Terrence W | Warrants Common Stock | Grant | Acquire A | No | No | 1 | 13,724 | 13.72 k | 13,724 |
31 Aug 23 | Michael S Abrams | Common Stock | Buy | Acquire P | No | No | 0.275 | 10,292 | 2.83 k | 10,292 |
31 Aug 23 | Michael S Abrams | Warrants Common Stock | Grant | Acquire A | No | No | 1 | 20,584 | 20.58 k | 20,584 |